Evommune, Inc. Raises $12.5M in Seed Funding to Accelerate the Development of Transformative Medicines for Chronic Inflammatory Diseases

LOS ALTOS, Calif., Nov. 18, 2020 /PRNewswire/ -- Evommune, Inc., an innovation engine in chronic inflammation, announced the successful completion of a $12.5 million...

Continue ReadingEvommune, Inc. Raises $12.5M in Seed Funding to Accelerate the Development of Transformative Medicines for Chronic Inflammatory Diseases

Evommune, Inc. Raises $12.5M in Seed Funding to Accelerate the Development of Transformative Medicines for Chronic Inflammatory Diseases

Los Altos, California –Nov. 18, 2020 –Evommune, Inc.,an innovation engine inchronic inflammation,announced the successful completion...

Continue ReadingEvommune, Inc. Raises $12.5M in Seed Funding to Accelerate the Development of Transformative Medicines for Chronic Inflammatory Diseases